Carisma Therapeutics
Sascha joined Carisma Therapeutics in March 2019 bringing more than 20 years of pharmaceutical and biotechnology experience including laboratory experience in biomaterials, stem cells, and immune-oncology, project and alliance management experience, and project leadership experience in early phase development. In her current role as Vice President of Scientific Operations she develops and implements the scientific operational strategy for Carisma’s continued growth and success.
Carisma Therapeutics
1 followers
Carisma Therapeutics is pioneering the development of CAR macrophages, a disruptive approach to immunotherapy to treat solid tumors.